Mosby's Home Care & Hospice Drug Handbook

(7)
Mosby's Home Care & Hospice Drug Handbook image
ISBN-10:

0815112262

ISBN-13:

9780815112266

Edition: 1
Released: Feb 15, 1999
Publisher: Mosby
Format: Paperback, 759 pages

Description:

When home and hospice care providers carry MOSBY'S HOME CARE AND HOSPICE DRUG HANDBOOK, they have the most current drug information at their side. It includes introductory chapters on Medicare, home infusion therapy, and special patient populations; detailed coverage of drugs commonly used in home and hospice care organized by disorder or condition; and a four-color drug identification atlas. This handy resource also highlights important information such as nursing implications, contraindications, patient education, and documentation for quality and reimbursement. It's the only handbook that focuses on the drug information that home care and hospice providers need when caring for their unique, growing patient population.

* Includes important foundation content in six introductory chapters that cover Medicare reimbursement of drug therapy, home infusion therapy, quality and safety, special patient populations, and other topics. * Organizes thirty-six home and hospice conditions alphabetically to allow fast retrieval of essential information. * Supplies general care considerations, medical diagnoses and ICD-9 codes, desired outcomes of therapy, nursing diagnoses, documentation and reimbursement tips, drug cost considerations, and informational resources for every condition. * Describes in detail hundreds of drugs identified as being the most commonly used medications in home care and hospice settings. * Provides a full-color drug identification guide organized alphabetically to help clinicians ensure that the patient receives the correct medication. * Supplies specific documentation tips for drugs used with each condition to insure quality and support reimbursement for home care and hospice organizations. * Includes an alphabetical list of all drugs covered by generic and trade name with page references for quick reference. * Highlights contraindications to alert clinicians to known sensitivities to a drug. * Presents patient education and teaching priorities, including information for taking medications safely in home or hospice settings. * Identifies common side effects and life-threatening adverse reactions for immediate recognition in emergency situations. * Includes extensive information on drug/drug and drug/food interactions for patient safety. * Features a functional, user-friendly two-color design that includes icons for nursing implications, contraindications, patient education and teaching priorities, and documentation for quality and reimbursement; color drug monograph headings; and screened index pages to facilitate easy location of information. * Includes an appendix on low income medication assistance programs since the high cost of many drugs can effect patient compliance. * Features a flexible binding for easy access and convenient use in home and hospice settings.

Best prices to buy, sell, or rent ISBN 9780815112266




Frequently Asked Questions about Mosby's Home Care & Hospice Drug Handbook

You can buy the Mosby's Home Care & Hospice Drug Handbook book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $8.16 on Amazon and is available from 18 sellers at the moment.

If you’re interested in selling back the Mosby's Home Care & Hospice Drug Handbook book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Mosby's Home Care & Hospice Drug Handbook book, the best buyback offer comes from and is $ for the book in good condition.

The Mosby's Home Care & Hospice Drug Handbook book is in very low demand now as the rank for the book is 3,385,904 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.